Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) in prostate cancer: PSMA-RADS classification and PROMISE criterias

被引：0
|
作者：
Robin, P. [1 ,2 ,5 ]
Palard-Novello, X. [3 ,4 ]
Bailly, C.
机构：
[1] Ctr Hosp Univ Brest, Serv Med Nucl, 2 Ave Foch, F-29269 Brest, France
[2] Univ Brest, CHU Brest, UMR 1304, Inserm, Brest, France
[3] Univ Rennes, CLCC Eugene Marquis, INSERM, LTSI UMR 1099, Ave Bataille Flandres Dunkerque, F-35042 Rennes, France
[4] Ctr Hosp Univ Nantes, Serv Med Nucl, Nantes, France
[5] Univ Brest, Ctr Hosp & Univ Brest, Inserm, UMR 1304,CHRU Brest,GETBO,Serv Med Nucl, 2 Ave Foch, F-29609 Brest, France
来源：
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2023年 / 47卷 / 05期
关键词：
Positron emission tomography; Prostate specific membrane antigen; receptor; Prostate cancer; Classifications; VERSION; PEARLS; EANM;
D O I：
10.1016/j.mednuc.2023.07.005
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) is nowadays widely used for the management of patients with prostate cancer during natural history of the disease. PSMA is not specific to prostate tissue, many benign and malignant diseases unrelated to prostate cancer are frequently found on PSMA-PET examinations, leading to false positives results and potentially to inadequate patient management. Various interpretation criteria have been proposed within classifications in order to standardize and homogenize PSMA-PET interpretation. This article describes, on the one hand the PSMA-RADS classification, and on the other hand the PROMISE criteria. (c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：270 / 275
页数：6
相关论文
共 50 条
  • [1] Procedure guideline for prostate-specific membran antigen targeting positron emission tomography (PSMA-PET) in prostate cancer
    Robin, P.
    Bailly, C.
    Palard-Novello, X.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (05): : 266 - 269
  • [2] Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications
    Shamus Moran
    Heather H. Cheng
    Emily Weg
    Eric H. Kim
    Delphine L. Chen
    Amir Iravani
    Joseph E. Ippolito
    Abdominal Radiology, 2024, 49 : 1288 - 1305
  • [3] Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications
    Moran, Shamus
    Cheng, Heather H.
    Weg, Emily
    Kim, Eric H.
    Chen, Delphine L.
    Iravani, Amir
    Ippolito, Joseph E.
    ABDOMINAL RADIOLOGY, 2024, 49 (04) : 1288 - 1305
  • [4] Stellenwert der PSMA-PET/CT („prostate-specific membrane antigen positron emission tomography/computed tomography“) im Rahmen des StagingsRole of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) in staging
    Claudia Kesch
    Tobias Franiel
    Christoph Berliner
    Wolfgang P. Fendler
    Ken Herrmann
    Boris Hadaschik
    Die Urologie, 2025, 64 (3) : 220 - 228
  • [5] Role of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) in staging
    Kesch, Claudia
    Franiel, Tobias
    Berliner, Christoph
    Fendler, Wolfgang P.
    Herrmann, Ken
    Hadaschik, Boris
    UROLOGIE, 2025,
  • [6] Prostate-specific membran antigen targeting positron emission tomography (PSMA-PET) in prostate cancer in France in 2023: Current use and perspectives
    Chanchou, M.
    Robin, P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (05): : 258 - 265
  • [7] Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
    Sungmin Woo
    Soleen Ghafoor
    Anton S. Becker
    Sangwon Han
    Andreas G. Wibmer
    Hedvig Hricak
    Irene A. Burger
    Heiko Schöder
    Hebert Alberto Vargas
    European Journal of Hybrid Imaging, 4
  • [8] Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
    Woo, Sungmin
    Ghafoor, Soleen
    Becker, Anton S.
    Han, Sangwon
    Wibmer, Andreas G.
    Hricak, Hedvig
    Burger, Irene A.
    Schoder, Heiko
    Vargas, Hebert Alberto
    EUROPEAN JOURNAL OF HYBRID IMAGING, 2020, 4 (01):
  • [9] Modeled clinical and economic outcomes of prostate-specific membrane antigen positron emission tomography (PSMA-PET) for the initial diagnosis and staging of patients with prostate cancer
    Yee, Christopher
    Xin, Yiqiao
    Kirson, Noam
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [10] Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
    Tateishi, Ukihide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 349 - 356
12345